KalshiKullanılabilirliği kontrol etKYC gerekli%2 ücretDoğrulanmış sonuçlanma verisiOrta düzey kalibreGüncel ima edilen olasılık
Before 2027 35%-1.0pt3 seçenek arasında lider
Piyasa kalitesi
42 / 100
Düşük kalite24s Hacim
₺107,7
Likidite
₺1,7 Mn
Yüksek likiditeSpread
8.0 pt
Geniş spreadPiyasa verileri
11 dakika önce güncellendi
24 Mar 26 14:00 UTC1 Oca 27 04:59 UTC
Trendler
İlgili Piyasalar
Bağlam için ilgili sorular; eşdeğer sözleşmelerin karşılaştırması değildir.
FDA moves BPC-157 to Category 1 by which date?
PolymarketHantavirus pandemic in 2026?
PolymarketWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
KalshiWill we get AGI before 2027?
Manifold MarketsFDA approves skin cancer vaccine by which date?
PolymarketMeasles cases in 2026?
KalshiKurallar
If the FDA announces Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List before Sep 1, 2026, then the market resolves to Yes.
Uzlaşma kaynağı:Food and Drug Administration
- The Payout Criterion is satisfied by placement of BPC-157 in either Category 1 or Category 1 Bulk Drug Substances Under Evaluation on the 503A Bulk Drug Substances list, as either designation restores compounding eligibility.
- Removal from Category 2 alone, without placement in Category 1, does not satisfy the Payout Criterion.
- If the FDA announces Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List before Nov 1, 2026, then the market resolves to Yes.
- If the FDA announces Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List before Jan 1, 2027, then the market resolves to Yes.
Açık piyasalar
Health & MedicinePOLYMARKETHantavirus pandemic in 2026?
- No-0.2pt97%
- Yes+0.2pt3%
- Toplam Hacim
- ₺878,6 Mn
- 24s Hacim
- ₺1,7 Mn
POLYMARKETEbola pandemic in 2026?
- No-0.1pt97%
- Yes+0.1pt3%
- Toplam Hacim
- ₺36,8 Mn
- 24s Hacim
- ₺200,1 B
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No97%
- Yes-0.7pt3%
- Toplam Hacim
- ₺91,6 Mn
- 24s Hacim
- ₺164 B
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 4000+1.0pt97%
- Above 600059%
+2 daha fazla sonuç
- Toplam Hacim
- ₺48,8 Mn
- 24s Hacim
- ₺153,5 B
POLYMARKETNew pandemic in 2026?
- No+1.0pt94.1%
- Yes-1.0pt5.9%
- Toplam Hacim
- ₺51,6 Mn
- 24s Hacim
- ₺78 B
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+1.0pt65%
- September41%
- June28%
- Toplam Hacim
- ₺4,7 Mn
- When will Compass Pathways submit a NDA for COMP360 psilocybin?
- When will the FDA approve Intellia Therapeutics' lonvo-z?
- Will 3 mg THC beverages be federally legal to sell?
- Cyclosporiasis cases reported in the US in 2026?
- FDA decision: Bepirovirsen by GlaxoSmithKline (in 2026)
- What will the average number of measles cases be during Trump's term?
- Will the FDA approve CagriSema?
- FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)
- Measles cases in U.S. in 2026?
- FDA decision: Ifinatamab Deruxtecan by Daiichi Sankyo (in 2026)
- FDA decision: Anitocabtagene Autoleucel (anito-cel) by Gilead Sciences (in 2026)
Sık sorulan sorular
- When will the FDA reclassify BPC-157 to Category 1? için güncel oranlar nedir?
- Kalshi, 9 Eylül 2026 itibarıyla Before 2027 için 35% fiyatlıyor.
- When will the FDA reclassify BPC-157 to Category 1? ne zaman sonuçlanacak?
- When will the FDA reclassify BPC-157 to Category 1? için öngörülen sonuçlanma tarihi 1 Ocak 2027.
- When will the FDA reclassify BPC-157 to Category 1? nasıl sonuçlandırılıyor?
- Kalshi bu piyasayı şu şekilde sonuçlandırır: If the FDA announces Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List before Sep 1, 2026, then the market resolves to Yes.